Without data you are just another person with an opinion. W. Edwards Deming
Andreas Krause, PhD
Positions held:
• Chief Scientific Officer CPP at Simulations Plus
• Lead Scientist Modeling and Simulation at Actelion and Idorsia Pharmaceuticals
• Senior Scientist at Pharsight Corporation
• (Senior) Modeling and Simulation Scientist at Novartis Pharma
LinkedIn profile
Education:
• MSc Statistics, minor Computer Science
• PhD statistics and economics
Scientific publications:
• 100+ manuscripts, 5 books
Scientific activities:
• Advisory board member at the Journal of Pharmacokinetics and Pharmacodynamics
• Advisory board member, former Editor-In-Chief at the journal Pharmaceutical Statistics
• Seasoned peer reviewer
• Member of the organization committee of the Basel M&S seminar, 2011-2025
Specialties:
• Pharmacometrics
• Graphics and data visualization
• concentration-QT modeling
• S-Plus and R user since 1987
• Training in data and model visualization (not only for pharmacometricians)
Teaching:
• PhD and MSc student supervision
• Numerous seminar presentations, workshops, and tutorials
Technical expertise:
Monolix, NONMEM, R, Berkeley Madonna, computing.
Success stories:
Ponesimod uptitration regimen, daridorexant adult and pediatric dosing, malaria compound shelving, treatment switching with P2Y12 agonists, and more.
Regulatory interactions:
bosentan, macitentan, selexipag (all pulmonary arterial hypertension), clazosentan (cerebral vasospasm), ponesimod (multiple sclerosis), daridorexant (insomnia), pediatric programs.
• Chief Scientific Officer CPP at Simulations Plus
• Lead Scientist Modeling and Simulation at Actelion and Idorsia Pharmaceuticals
• Senior Scientist at Pharsight Corporation
• (Senior) Modeling and Simulation Scientist at Novartis Pharma
LinkedIn profile
Education:
• MSc Statistics, minor Computer Science
• PhD statistics and economics
Scientific publications:
• 100+ manuscripts, 5 books
Scientific activities:
• Advisory board member at the Journal of Pharmacokinetics and Pharmacodynamics
• Advisory board member, former Editor-In-Chief at the journal Pharmaceutical Statistics
• Seasoned peer reviewer
• Member of the organization committee of the Basel M&S seminar, 2011-2025
Specialties:
• Pharmacometrics
• Graphics and data visualization
• concentration-QT modeling
• S-Plus and R user since 1987
• Training in data and model visualization (not only for pharmacometricians)
Teaching:
• PhD and MSc student supervision
• Numerous seminar presentations, workshops, and tutorials
Technical expertise:
Monolix, NONMEM, R, Berkeley Madonna, computing.
Success stories:
Ponesimod uptitration regimen, daridorexant adult and pediatric dosing, malaria compound shelving, treatment switching with P2Y12 agonists, and more.
Regulatory interactions:
bosentan, macitentan, selexipag (all pulmonary arterial hypertension), clazosentan (cerebral vasospasm), ponesimod (multiple sclerosis), daridorexant (insomnia), pediatric programs.
Collaborators
Other partners (companies, individuals) from a network in the wide world of clinical drug development may be involved on project teams.